²©Ã¨µÇ¼·ÆÂɱö

ѧУÊ×Ò³    |     English
Ò©¼Áѧѧ²¿
ÄúËùÔÚλÖÃ: Ê×Ò³ > ʦ×ʶÓÎé > Ò©¼Áѧѧ²¿ > ÕýÎÄ
Áè¼Ò¿¡
·¢²¼Ê±¼ä£º2019-06-25      À´Ô´£º       µã»÷£º


Áè¼Ò¿¡

Ö°³Æ£º½ÌÊÚ Ñ§Î»£º²©Ê¿ ¸öÈË»ñµÃµÄÈÙÓþ£ºÏÖÈβ©Ã¨µÇ¼·ÆÂɱö²©Ã¨µÇ¼·ÆÂɱöѧԺҩ¼Á(ÖÆÒ©¹¤³Ì)½ÌÑÐÊÒ¸±Ö÷ÈΡ£1997Äê±ÏÒµÓÚ²©Ã¨µÇ¼·ÆÂɱö²©Ã¨µÇ¼·ÆÂɱöѧԺ»ñ˶ʿѧ룬2004Äê±ÏÒµÓÚ²©Ã¨µÇ¼·ÆÂɱö²©Ã¨µÇ¼·ÆÂɱöѧԺ»ñ²©Ê¿Ñ§Î»¡£±ÏÒµºóÓÚ²©Ã¨µÇ¼·ÆÂɱö²©Ã¨µÇ¼·ÆÂɱöѧԺ´ÓÊÂÒ©¼Áѧ¼°Ïà¹Ø¿Î³ÌµÄ½Ìѧ¹¤×÷£¬¶à´Î»ñµÃ´óѧ¼°Ñ§Ôº×éÖ¯µÄ½Ìѧ±È½Ï¡¢¿Î¼þÖÆ×÷±È½ÏÒ»µÈ½±£¬²¢Ôø±»ÆÀΪ¡°Ê¦µÂ±ê±ø¡±¡£ÏÖ´ÓÊÂÒ©ÎïÖÆ¼ÁмÁÐÍÓëм¼ÊõÏà¹ØÑо¿£¬Ö÷ÒªÑо¿ÁìÓòÉæ¼°²©Ã¨µÇ¼·ÆÂɱö¸´·½Ò©ÎﶯÁ¦Ñ§¡¢¾Ö²¿Ò©ÎﶯÁ¦Ñ§¡¢¾­Æ¤¸øÒ©ÏµÍ³¼°Ö×Áö°ÐÏòµÝҩϵͳµÈ·½Ãæ¡£×Ô´Ó2007Ä꿪ʼÅàÑøË¶Ê¿Ñо¿Éú£¬ÖÁ½ñÒѾ­ÅàÑøÁË12½ìÑо¿Éú¹²21Ãû˶ʿÑо¿Éú¡£ÔøÖ÷³ÖµÄ¿ÆÑпÎÌâ°üÀ¨¹ú¼Ò¼¶¡¢Ê¡²¿¼¶ÏîĿʮÓàÏÔÚ¹úÄÚÍâ¿ÆÑ§ÆÚ¿¯ÉÏÒÑ·¢±íѧÊõÂÛÎÄÊýʮƪ¡£

½ÌÓý¡¢¹¤×÷¾­Àú

1994Äê±ÏÒµÓÚ¹ãÖÝÖÐҽѧԺ²©Ã¨µÇ¼·ÆÂɱöϵ±¾¿Æ²¢»ñѧʿѧ룬1997Äê±È½ÏÓÚ²©Ã¨µÇ¼·ÆÂɱö²©Ã¨µÇ¼·ÆÂɱöѧԺ»ñ˶ʿѧ룬±ÏÒµºóÔÚ²©Ã¨µÇ¼·ÆÂɱöÐÅÏ¢ÍøÂç¹ÜÀíÖÐÐÄ´ÓÊÂҽѧÐÅÏ¢¹¤×÷£¬2001Äê~2004ÄêÓÚ²©Ã¨µÇ¼·ÆÂɱö²©Ã¨µÇ¼·ÆÂɱöѧԺ¹¥¶Á²©Ê¿Ñ§Î»£¬2004Äê»ñµÃ²©Ã¨µÇ¼·ÆÂɱöѧ²©Ê¿£¬2004ÄêÖÁ½ñ£¬ÓÚ²©Ã¨µÇ¼·ÆÂɱö²©Ã¨µÇ¼·ÆÂɱöѧԺҩ¼Á(ÖÆÒ©¹¤³Ì)½ÌÑÐÊÒ´ÓʽÌѧºÍ¿ÆÑй¤×÷¡£2009Äê12Ô»ñµÃ²©Ã¨µÇ¼·ÆÂɱöѧ½ÌÊÚ×ʸñ£¬Èç½ñµ£ÈÎÒ©¼Á(ÖÆÒ©¹¤³Ì)½ÌÑÐÊÒ¸±Ö÷ÈΡ£

Ñо¿·½Ïò

´ÓÊÂÒ©ÎïÖÆ¼ÁмÁÐÍÓëм¼ÊõÏà¹ØÑо¿£¬Ö÷ÒªÑо¿ÁìÓòÉæ¼°²©Ã¨µÇ¼·ÆÂɱö¸´·½Ò©ÎﶯÁ¦Ñ§¡¢¾Ö²¿Ò©ÎﶯÁ¦Ñ§¡¢¾­Æ¤¸øÒ©ÏµÍ³¼°Ö×Áö°ÐÏòµÝҩϵͳµÈ·½Ãæ¡£

¿ÆÑм°½Ìѧ¿ÎÌâ

1¡¢¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÃæÉÏÏîÄ¿£¬81873227£¬»ùÓÚÇÊÖ¬×éѧÓëÖÊÆ×³ÉÏñ¼¼ÊõµÄ²¹Ñô»¹ÎåÌÀÄÔȱѪËðÉ˱£»¤µÄʱ¿ÕÌØÐÔ¼°×÷ÓûúÖÆÑо¿£¬2019/1-2022/12£¬57ÍòÔª£¬ÔÚÑУ¬²Î¼Ó(ÅÅÃû2)
2¡¢¹ã¶«Ê¡¿Æ¼¼¼Æ»®ÏîÄ¿£¬2014A020221102£¬»ùÓÚ΢͸Îö¼¼Êõ-´úл×éѧµÄµ¤²Î´¨ÜºÒ©¶Ô²»Í¬ÅäÎéµÄÄÔ¾Ö²¿PK-PDÑо¿£¬2016/05-2018/04(ÑÓÆÚ½áÌâÖÁ2019/04),30ÍòÔª£¬ÔÚÑУ¬²Î¼Ó(ÅÅÃû2)
3¡¢¹ã¶«Ê¡¿Æ¼¼¼Æ»®ÏîÄ¿£¬2014A020210022£¬ÐÂÐÍÉùÃô¼Á¶þÇâß²·Ôe6µÄÉùÃôÄÉÃ×Ö¬ÖÊÌå°ÐÏò¸øÒ©ÏµÍ³¼°Ö×Áö¾Ö²¿Ò©¶¯Ñ§Ñо¿£¬2015/06-2018/05£¬20ÍòÔª£¬ÒѽáÌ⣬Ö÷³Ö
4¡¢¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÃæÉÏÏîÄ¿£¬81373973£¬ÄÔ΢͸Îö/¼¤¹âÉ¢°ß³ÉÏñ¼¼ÊõÓëPK/PD½áºÏ½øÐв¹Ñô»¹ÎåÌÀ¡°ÒæÆøÐÐѪÉúС±»úÖÆµÄÑо¿£¬2014/1-2017/12£¬70ÍòÔª£¬ÒѽáÌ⣬²Î¼Ó
5¡¢¹ã¶«Ê¡¿Æ¼¼¼Æ»®ÏîÄ¿£¬2010B030700035£¬¾Û½¹³¬ÉùÓëÈÈÃôÖ¬ÖÊÌåÁªÓõIJ©Ã¨µÇ¼·ÆÂɱö¿¹Ö×Áö³É·Ö°ÐÏòÊÍÒ©¼¼Êõ¼°Ö×Áö¾Ö²¿Ò©¶¯Ñ§Î¢Í¸ÎöÑо¿£¬2010/1-2012/12£¬5ÍòÔª£¬ÒѽáÌ⣬Ö÷³Ö¡£
6¡¢¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÃæÉÏÏîÄ¿£¬30772791£¬²©Ã¨µÇ¼·ÆÂɱöÒ©¶¯Ñ§ÖеÄ΢͸ÎöÓëÎȶ¨Í¬Î»Ëرê¼ÇÁªÓü¼ÊõÑо¿£¬2008/01-2010/12£¬30ÍòÔª£¬ÒѽáÌ⣬Ö÷³Ö¡£
7¡¢¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÃæÉÏÏîÄ¿£¬²©Ã¨µÇ¼·ÆÂɱö¾­Æ¤¸øÒ©ÏµÍ³µÄPK-PD½áºÏÄ£ÐÍÑо¿£¬2007/01-2009/12£¬30ÍòÔª£¬ÒѽáÌ⣬²ÎÓë¡£
8¡¢¹ãÖÝÊпƼ¼¼Æ»®ÏîÄ¿£¬2006Z3-E5021£¬»·Î¬»ÆÑîÐÇDиøÒ©ÏµÍ³¿ØÊÍÌù¼ÁµÄÑо¿£¬2006/03-2009/02£¬20ÍòÔª£¬ÒѽáÌ⣬²ÎÓë¡£
9¡¢¹ã¶«Ê¡×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿£¬0500063£¬Î¢Í¸Îö¼¼ÊõÔÚ²©Ã¨µÇ¼·ÆÂɱö¾­Æ¤¸øÒ©ÏµÍ³Ò©¶¯Ñ§Ñо¿ÖеÄÓ¦Óã¬2006/01-2008/12£¬2ÍòÔª£¬ÒѽáÌ⣬Ö÷³Ö¡£
10¡¢²©Ã¨µÇ¼·ÆÂɱö¿ÆÑд´Ð»ù½ðÏîÄ¿£¬ÀûÓÃ΢͸Îö¼¼ÊõÑо¿²©Ã¨µÇ¼·ÆÂɱö¾­Æ¤¸øÒ©ÏµÍ³µÄÒ©¶¯Ñ§£¬2004£¬1ÍòÔª£¬ÒѽáÌ⣬Ö÷³Ö¡£
11¡¢¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÃæÉÏÏîÄ¿£¬²©Ã¨µÇ¼·ÆÂɱö¾­Æ¤¸øÒ©ÏµÍ³¾Ö²¿Ò©¶¯Ñ§Ñо¿£¬2003£¬30ÍòÔª£¬ÒѽáÌ⣬²ÎÓë¡£
12¡¢¹ã¶«Ê¡×ÔÈ»¿ÆÑ§»ù½ðÃæÉÏÏîÄ¿£¬31473£¬²©Ã¨µÇ¼·ÆÂɱö¾­Æ¤¸øÒ©ÏµÍ³¾Ö²¿Ò©¶¯Ñ§Ñо¿¼°PK-PDÄ£Ð͵Ľ¨Á¢£¬2004/01-2005/12£¬5ÍòÔª£¬ÒѽáÌ⣬²ÎÓë¡£
13¡¢¹ã¶«Ê¡¿Æ¼¼¼Æ»®ÏîÄ¿£¬2003C34404£¬ÇàÌÙ¼î¹Ç¼ÜÐͰÐÏò¿ØÊÍ͸ƤÌù¼ÁÑо¿£¬2003/10-2005/10£¬5ÍòÔª£¬ÒѽáÌ⣬²ÎÓë¡£
14¡¢¹ú¼ÒÖÐÒ½Ò©¹ÜÀí¾ÖÖÐÒ½Ò©¿ÆÑ§¼¼ÊõÑо¿×¨ÏèµÇ¼·ÆÂɱöÑо¿¿ÎÌ⣬²©Ã¨µÇ¼·ÆÂɱö¾­Æ¤¸øÒ©ÖƼÁÉúÎïµÈЧÐÔÑо¿£¬2003/03-2005/03£¬5ÍòÔª£¬ÒѽáÌ⣬²ÎÓë¡£
15¡¢¹ãÖÝÊпƼ¼¼Æ»®ÏîÄ¿£¬2002Z3-E5011£¬ÇàÌÙ¼î͸ƤÌù¼ÁµÄ¿ª·¢£¬2002Äê8ÔÂ-2004Äê12Ô£¬ÒѽáÌ⣬²ÎÓë¡£

³Ðµ£¿Î³Ì

ĿǰÖ÷Òª³Ðµ£Ò©Ñ§¼°Ò©ÎïÖÆ¼Áרҵ(±¾¿Æ¼°³É½Ì)µÄ¡¶Ò©¼Áѧ¡·¿ÎÌýÌѧ¼°ÊµÑé½Ìѧ£¬Ôø¾­³Ðµ£µÄÆäËû½Ìѧ¿Î³ÌÓС¶²©Ã¨µÇ¼·ÆÂɱöÒ©¼Áѧ¡·¡¢¡¶ÉúÎïÒ©¼Áѧ¡·¡¢¡¶¹¤ÒµÒ©¼Áѧ¡·µÈ¡£

´ú±íÐԳɼ¨

1¡¢ÔÚ2006Ä격èµÇ¼·ÆÂɱö¾Ù°ìµÄ½ÌÓý¼¼Êõ³É¹û±ÈÈüÖУ¬¶ÀÁ¢ÖÆ×÷µÄ¡¶ÉúÎïÒ©¼Áѧ¡·¶àýÌå½Ìѧ¿Î¼þ»ñµÃÒ»µÈ½±¡£
2¡¢ÔÚ2007Ä격èµÇ¼·ÆÂɱöµç×ӽ̲ÄÖÆ×÷±ÈÈüÖУ¬¶ÀÁ¢ÖÆ×÷µÄ¡¶½ºÄÒ¼Á¡·µç×ӻõƻñµÃÒ»µÈ½± 2006Äê²ÎÓëµÄ¡¶ÖÐÎ÷Ò½½áºÏ˼·ºÍ·½·¨µÄÑо¿Óë½Ìѧʵ¼ù¡·µÄ³É¹ûÑо¿·Ö±ð»ñºþÄÏÊ¡¸ßµÈ½ÌÓýÊ¡¼¶½Ìѧ³É¹û¶þµÈ½±¼°ºþÄÏÖÐÒ½Ò©´óѧ½Ìѧ³É¹ûÒ»µÈ½±¡£
3¡¢ÏȺóÈý´Î×÷ΪÖ÷½²È˶ÔÎÒУÈονÌʦ½øÐС°½ÌѧPPTÖÆ×÷¡±Åàѵ£ºµÚÒ»´Î2008Äê1Ô£¬ÓÉ»ù´¡Ò½Ñ§ÔºÖ÷°ì£»µÚ¶þ´Î2008Äê6Ô£¬Óɲ©Ã¨µÇ¼·ÆÂɱöѧԺÖ÷°ì£»µÚÈý´Î2008Äê11Ô£¬ÓɽÌÎñ´¦Ö÷°ì¡£
4¡¢2009Äê±»²©Ã¨µÇ¼·ÆÂɱö²©Ã¨µÇ¼·ÆÂɱöѧԺÆÀΪ¡°Ê¦µÂ±ê±ø¡±¡£

´ú±íÐÔÂÛÎÄÂÛÖø

  • 1.ÕÅìñµÂ£¬Íõ°²Ôª£¬ºÂ½¨¶¬£¬Ð»²¨£¬Áè¼Ò¿¡*£¬Ö캣ÃÄ£¬ºØâù£¬Ìï½ð½à£¬¶þÇâß²·Ôe6Ö¬ÖÊÌåÔÚºÉÁöСÊóÌåÄÚµÄÒ©¶¯Ñ§¼°°ÐÏòÐÔ·ÖÎö£¬ÖйúʵÑé·½¼ÁѧÔÓÖ¾£¬2018, 24(13): 71-77
    2.Hai-Mei Zhu, Jin-Hui Gu, Yi Xie, Bo Xie* & Jia-Jun Ling*, Hydroxycamptothecin liposomes based on thermal and magnetic dual-responsive system: preparation, in vitro and in vivo antitumor activity, microdialysis-based tumor pharmacokinetics, Journal of Drug Targeting, 2018,26(4):345-356
    3.Ö캣ÃÄ£¬Ð»Ò㣬л²¨£¬Áè¼Ò¿¡*£¬»ùÓÚ΢͸Îö²ÉÑù¼¼Êõ·ÖÎöôÇ»ùϲÊ÷¼î´ÅÐÔÖ¬ÖÊÌåÔÚ´óÊóÌåÄÚµÄÒ©´ú¶¯Á¦Ñ§£¬ÖйúʵÑé·½¼ÁѧÔÓÖ¾£¬2017,23(18):64-70
    4.ÕÔÑ©Àö£¬Áè¼Ò¿¡*£¬Îº¼Ò±££¬»ÆËÕËÕ£¬Ö¸ÎÆÍ¼Æ×²â¶¨ËÄÄæÌÀ6ÖÖÓÐЧ³É·ÖµÄº¬Á¿£¬ÖÐÒ½Ò©µ¼±¨£¬2016,22(17):53-58
    5.ÕÔÑ©Àö£¬Áè¼Ò¿¡*£¬Îº¼Ò±££¬ ²»Í¬Åú´ÎËÄÄæÌÀÌáÈ¡ÎïÖ¸ÎÆÍ¼Æ×ÓëÆä¿¹Ðļ¡È±ÑªµÄÆ×ЧѧÑо¿£¬±±·½Ò©Ñ§£¬2015,12(12):98-100
    6.Áè¼Ò¿¡*£¬ÎâÐã¾ý£¬¸¶Ï棬Îȶ¨Í¬Î»ËØÄÚ±ê΢͸Îö¼¼ÊõÓÃÓÚÄá¹Å¶¡µÄÒ©¶¯Ñ§Ñо¿£¬Öйú²©Ã¨µÇ¼·ÆÂɱöÔÓÖ¾£¬2012,37(1):104-108
    7.ÎâÐã¾ý£¬Áè¼Ò¿¡*£¬¸¶ Ïæ£¬ÇØÔó»Û£¬ÕÅÓ¢·á£¬ÀûÓÃÎȶ¨Í¬Î»ËØÄÚ±ê΢͸Îö¼¼Êõ½øÐÐÄá¹Å¶¡ÄÔ¾Ö²¿Ò©¶¯Ñ§Ñо¿£¬Ò©Ñ§Ñ§±¨£¬2011,46(3):333-337
    8.Áè¼Ò¿¡*£¬³ÂÏ裬Äڱ귨²â¶¨Ñ̼î΢͸Îö»ØÊÕÂʵĿÉÐÐÐÔÑо¿£¬Ò©Ñ§Ñ§±¨£¬2010,45(5):632-635
    9.ÖÜÀòÁᣬÁè¼Ò¿¡£¬ÕÅÓ¢·á£¬ÍõÀûʤ£¬ÖܾÁÑþ£¬ÓÚÑ󣬵ȣ¬²©Ã¨µÇ¼·ÆÂɱöÖÆ¼ÁÒ©ÎﶯÁ¦Ñ§£¬ÈËÃñÎÀÉú³ö°æÉ磬68.1Íò×Ö£¬2012
    10.»ÆËÕËÕ£¬Ð»²¨£¬Áè¼Ò¿¡*£¬ºÂ½¨¶¬£¬¶þÇâß²·Ôe6´ÅÐÔÉùÃôÄÉÃ×Ö¬ÖÊÌåµÄÖÆ±¸¼°ÖÊÁ¿ÆÀ¼Û£¬ÖйúʵÑé·½¼ÁѧÔÓÖ¾£¬2017,23(8):21-26
    11.Jia-bao Wei, Qiao Lai, Stepan P. Shumyak, Lan-fang Xu, Chen-xue Zhang, Jia-junLing, YangYu*, An LC/MS quantitative and microdialysis method for cyclovirobuxine D pharmacokinetics in rat plasma and brain: The pharmacokinetic comparison of three different drug delivery routes. Journal of Chromatography B Analytical Tec hnologies in the Biomedical & Life Sciences, 2015, 1002:185-193
    12.µËæ©æ©£¬Áè¼Ò¿¡*£¬ÉÛÔã¬Õý½»Éè¼ÆÓÅ»¯²Î¸½¿Ú±ÀƬ´¦·½£¬ÖÐÒ½Ò©µ¼±¨£¬2015,21(18):41-43
    13.ÉÛÔã¬Áè¼Ò¿¡*£¬µËæ©æ©£¬Î¢ÖùÀëÐĸßЧҺÏà·¨²â¶¨¼ª·ÇÌæÄáÖ¬ÖÊÌå°ü·âÂÊ£¬±±·½Ò©Ñ§£¬2015,12(1):15-17
    14.ºîÔ¶öΣ¬Ð»²¨£¬ÑÏ×ÓÁᣬÉÛÔã¬µËæ©æ©£¬Áè¼Ò¿¡*£¬¸ßЧҺÏàÉ«Æ×·¨²â¶¨´óÊóѪ½¬Öмª·ÇÌæÄáŨ¶È¼°ÆäÒ©¶¯Ñ§£¬ºþ±±Ãñ×åѧԺѧ±¨(ҽѧ°æ)£¬2014,31(1):15-18
    15.л²¨£¬ºòÔ¶öΣ¬ÕÅΪÃñ£¬Áè¼Ò¿¡*£¬ÁÖ½ðÈÝ£¬µËæ©æ©£¬Î¢Í¸Îö¼¼ÊõÓ¦ÓÃÓÚGefitinibÒ©¶¯Ñ§²ÉÑùµÄ¿ÉÐÐÐÔÑо¿£¬ÖйúÁÙ´²Ò©ÀíѧÓëÖÎÁÆÑ§£¬2013,18(12):1369-1374
    16.Íõ°²Ôª£¬Áè¼Ò¿¡*£¬ÐìÔÂÔ²£¬Ð»²¨£¬ºÂ½¨¶¬£¬¶þÇâß²·Ôe6Ö¬ÖÊÌåµÄÖÆ±¸¼°Ó°ÏìÒòËØ¿¼²ì£¬ÖйúʵÑé·½¼ÁѧÔÓÖ¾£¬2013,19(5):36-39
    17.Íõ°²Ôª£¬Áè¼Ò¿¡*£¬Ð»²¨£¬ÐìÔÂÔ²£¬Ö×ÁöÉù¶¯Á¦ÁÆ·¨ÖеÄÉùÃô¼ÁÑо¿ÏÖ×´¼°Ó¦ÓÃǰ¾°£¬ÖйúÏÖ´úÓ¦ÓÃҩѧ£¬2013,30(2):219-223
    18.ÐìÔÂÔ²£¬Áè¼Ò¿¡*£¬Ð»Ò㣬Íõ°²Ôª£¬¶þÇâß²·Ôe6΢͸Îö»ØÊÕÂʵÄÌåÍâ²â¶¨·½·¨¼°Ó°ÏìÒòËØÑо¿£¬ÖйúʵÑé·½¼ÁѧÔÓÖ¾£¬2012,18(24):109-113
    19.Áè¼Ò¿¡*£¬¹Å½õ»Ô£¬Ð»Ò㣬Ф÷ºì£¬Ð»²¨£¬ôÇ»ùϲÊ÷¼î´ÅÐÔÖ¬ÖÊÌåµÄÖÆ±¸¼°Æä°ÐÏòÐÔÌØÕ÷ÊÔÑ飬ÖйúʵÑé·½¼ÁѧÔÓÖ¾£¬2012,18(16):19-23
    20.лÒ㣬Áè¼Ò¿¡*£¬¹Å½õ»Ô£¬ôÇ»ùϲÊ÷¼î΢͸Îö»ØÊÕÂʵÄÌåÍâÑо¿£¬Öйú²©Ã¨µÇ¼·ÆÂɱöÔÓÖ¾£¬2012,37(10):1491-1493
    21.¹Å½õ»Ô£¬Áè¼Ò¿¡*£¬Ð»Ò㣬Ф÷ºì£¬ôÇ»ùϲÊ÷¼îÖ¬ÖÊÌåµÄÖÆ±¸ÓëÐÔÖÊÑо¿£¬±±·½Ò©Ñ§£¬2012,9(4):23-25
    22.¸¶Ï棬Áè¼Ò¿¡*£¬ÎâÐã¾ý£¬ÑªÒºÖ¸ÎÆÍ¼Æ×ÔÚ²©Ã¨µÇ¼·ÆÂɱöÒ©¶¯Ñ§Ñо¿ÖеÄÓ¦Ó㬲©Ã¨µÇ¼·ÆÂɱöѧ±¨£¬2011,28(4):452-456
    23.л²¨£¬Áè¼Ò¿¡*£¬ÎâÐã¾ý£¬»ÆÑ©ÇÙ£¬Î¢Í¸Îö²ÉÑù¼¼Êõ¶Ô¼ªÎ÷Ëû±õŨ¶È¶¯Ì¬²â¶¨µÄÌåÍâÑо¿£¬²©Ã¨µÇ¼·ÆÂɱöѧ±¨£¬2011,28(4):430-438
    24.¸¶Ï棬Áè¼Ò¿¡*£¬ÎâÐã¾ý£¬×¢ÉäÓÃË«»ÆÁ¬(¶³¸É) ΢͸Îö»ØÊÕÂʵÄÌåÍâ²â¶¨·½·¨£¬Öйú²©Ã¨µÇ¼·ÆÂɱöÔÓÖ¾£¬2011,36(14):1951-1954
    25.Áè¼Ò¿¡*£¬³ÂÁÁ£¬ÐìêÍ£¬ÒºÖÊÁªÓÃÉ«Æ×·¨Í¬Ê±²â¶¨Î¢Í¸ÎöÑùÆ·ÖÐÄá¹Å¶¡Óëë®´úÄá¹Å¶¡µÄº¬Á¿£¬ÏÖ´ú²©Ã¨µÇ¼·ÆÂɱöÑо¿Óëʵ¼ù£¬2010,24(6):71-74
    26.л²¨£¬Áè¼Ò¿¡*£¬ÎâÐã¾ý£¬¸¶Ï棬»ÆÑ©ÇÙ£¬Î¢Í¸Îö¼¼ÊõÓÃÓÚ»¯ÁÆÒ©Î¡ª¼ªÎ÷Ëû±õµÄÌåÄÚÒ©¶¯Ñ§³õ²½Ñо¿£¬ÖйúÁÙ´²Ò©ÀíѧÓëÖÎÁÆÑ§£¬2010,15(9):1035-1039
    27.³ÂÏ裬Áè¼Ò¿¡*£¬³ÂÁÁ£¬Ñ̼î΢͸Îö»ØÊÕÂʵÄÌåÍâ²â¶¨·½·¨¼°Ó°ÏìÒòËØÑо¿£¬²©Ã¨µÇ¼·ÆÂɱöѧ±¨£¬2010,27(2):159-163
    28.Áè¼Ò¿¡*£¬Ð»²¨£¬ÍõÑÒ£¬ÖÜÀòÁᣬÀûÓÃ΢͸ÎöÈ¡Ñù¼¼ÊõʵÏÖÆ¤·ô¾Ö²¿ÇàÌټÁ¿µÄ¶¯Ì¬²â¶¨£¬²©Ã¨µÇ¼·ÆÂɱö²Ä£¬2008,31(7):1062-1065

ÉÏÒ»Ìõ£ºÂíÑà

ÏÂÒ»Ìõ£ºÍõÀûʤ


²©Ã¨µÇ¼·ÆÂɱö(Öйú)|ios|AndroidͨÓðæAPP×îаæ